Alessandro Zuddas Award for Child and Adolescent Neuropsychopharmacology

This award recognised excellent research in the treatment and prevention of disorders of the brain for children and adolescents, including preclinical research, and clinical science, and evidence-based approaches to prevention.

Please note that this award has been discontinued as of 2026.

The award was given annually, based on the abstract submitted for poster presentation at the ECNP Congress. 

The award came with a cash prize of EUR 500 and was conferred at the ECNP Congress.

Who was eligible?

All poster presenters at the ECNP Congress were eligible to win the award.

Previous winner

Year Winner Poster
2025

Lisa Geertjens, the Netherlands

PS03-2159
Individual bumetanide responses on patient-reported-outcomes-measures measuring sensory reactivity in children with neurodevelopmental disorders: a multiple baseline single-case experimental design

2024

Jesus Camacho
Spain

P1172
Meta-analyses on the prevalence of negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis